United States · Series F startup

Who invested in Adaptive Biotechnologies

6 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Funding summaryUpdated 26 Oct 2026

$407Mraised across 6 rounds since 2013, from 6 sources

$5.0MVenture$2.5MGrant$5.0MSeries C$105MSeries D$94MSeries E$195MSeries F
Latest round
Series F, $195MMay 2015
Step-upi
2.1×
Investors
5
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20142015
$5.0MVenture$2.5MGrant$5.0MSeries C$105MSeries D$94MSeries E$195MSeries F
First round
Venture, $5.0M
Jul 2013
Biggest round
$195M
Series F · May 2015
Usual gap between rounds
7 months
the median of 4

The rounds

  1. May 2015
    Series F$195M4 new

    From a historical funding recordSEC filing: $195M sold, first sale May 2015

  2. Jan 2015
    Series E$94M

    No investor was named in the report.

    From a historical funding recordSEC filing: $96M sold, first sale Jan 2015

  3. Apr 2014
    Series D$105M1 new

    From a historical funding recordSEC filing: $105M sold, first sale Apr 2014

  4. Apr 2014
    Series C$5.0M

    No investor was named in the report.

    From a historical funding recordSEC filing: $105M sold, first sale Apr 2014

  5. Sept 2013
    Grant$2.5M

    No investor was named in the report.

    Reported by genomeweb.comSEC filing: $5.0M sold, first sale Jul 2013

  6. Jul 2013
    Venture$5.0M

    No investor was named in the report.

    Reported by sec.govSEC filing: $5.0M sold, first sale Jul 2013

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Venture2013Grant2013Series C2014Series D2014Series E2015Series F2015Viking GlobalRock Springs CapitalTiger Management CorporationMatrix CapitalSenator Investment Group

Everyone who backed them

Viking GlobalVC firm1round
Rock Springs CapitalHedge fund1round
Tiger Management CorporationGrowth equity1round
Matrix CapitalFamily office1round
Senator Investment GroupGrowth equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Adaptive Biotechnologies as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Decheng CapitalVC firmPer its own site
Rona HoldingsPrivate equityPer its own site

Quick answers about Adaptive Biotechnologies

Who invested in Adaptive Biotechnologies?

Adaptive Biotechnologies's investors include Viking Global, Rock Springs Capital, Tiger Management Corporation, Matrix Capital and Senator Investment Group.

How much has Adaptive Biotechnologies raised?

Adaptive Biotechnologies has raised $407M across 6 rounds since 2013.

When did Adaptive Biotechnologies last raise?

Adaptive Biotechnologies's most recent round was a Series F of $195M in May 2015.

What was Adaptive Biotechnologies's biggest round?

Its most recent round, $195M in May 2015, is also its largest on record.

Who backed Adaptive Biotechnologies first?

Adaptive Biotechnologies's first round on record, in Apr 2014, was backed by Viking Global.

What stage is Adaptive Biotechnologies at?

Adaptive Biotechnologies's latest named round is a Series F, in May 2015.

Where is Adaptive Biotechnologies based?

Adaptive Biotechnologies is based in the United States.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.